-
公开(公告)号:US20210330378A1
公开(公告)日:2021-10-28
申请号:US17365868
申请日:2021-07-01
发明人: Denise Zarins , Hanson Gifford, III , Mark E. Deem , Douglas Sutton , Howard R. Levin , Mark Gelfand
摘要: Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
-
公开(公告)号:US10293190B2
公开(公告)日:2019-05-21
申请号:US14875333
申请日:2015-10-05
发明人: Denise Zarins , Nicolas Zadno , Benjamin J. Clark , Erik Thai , Howard R. Levin , Mark Gelfand
IPC分类号: A61F7/00 , A61F7/12 , A61M5/44 , A61N1/28 , A61N1/36 , A61N1/40 , A61N5/04 , A61N7/00 , A61N7/02 , A61B18/00 , A61B18/02 , A61B18/04 , A61B18/12 , A61B18/14
摘要: Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues.
-
公开(公告)号:US20190090943A1
公开(公告)日:2019-03-28
申请号:US16141042
申请日:2018-09-25
发明人: Denise Zarins , Nicolas Zadno , Benjamin J. Clark , Erik Thai
IPC分类号: A61B18/14 , A61N1/36 , A61B17/12 , A61N1/40 , A61N1/32 , A61M25/10 , A61B18/00 , A61N1/372 , A61M25/01
CPC分类号: A61B18/1492 , A61B17/12136 , A61B2018/00083 , A61B2018/00285 , A61B2018/00434 , A61B2018/00613 , A61M25/0108 , A61M25/10 , A61N1/327 , A61N1/36007 , A61N1/36121 , A61N1/36182 , A61N1/37205 , A61N1/40
摘要: Methods and apparatus are provided for intravascularly-induced neuromodulation using a pulsed electric field, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation, etc., in target neural fibers. In some embodiments, the intravascular PEF system comprises a catheter having a pair of bipolar electrodes for delivering the PEF, with a first electrode positioned on a first side of an impedance-altering element and a second electrode positioned on an opposing side of the impedance-altering element. A length of the electrodes, as well as a separation distance between the first and second electrodes, may be specified such that, with the impedance-altering element deployed in a manner that locally increases impedance within a patient's vessel, e.g., with the impedance-altering element deployed into contact with the vessel wall at a treatment site within the patient's vasculature, a magnitude of applied voltage delivered across the bipolar electrodes necessary to achieve desired neuromodulation is reduced relative to an intravascular PEF system having similarly spaced electrodes but no (or an undeployed) impedance-altering element. In a preferred embodiment, the impedance-altering element comprises an inflatable balloon configured to locally increase impedance within a patient's vasculature. The methods and apparatus of the present invention may be used to modulate a neural fiber that contributes to renal function.
-
4.
公开(公告)号:US20180271591A1
公开(公告)日:2018-09-27
申请号:US15862452
申请日:2018-01-04
发明人: Denise Zarins , Hanson Gifford, III , Mark Deem , Douglas Sutton , Howard R. Levin , Mark Gelfand
IPC分类号: A61B18/14
CPC分类号: A61B18/1492 , A61B2018/0022 , A61B2018/00267 , A61B2018/00351 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00613 , A61F7/12 , A61F2007/126 , A61M5/14276 , A61M2210/1082 , A61M2210/12 , A61N1/05 , A61N1/327 , A61N1/36017 , A61N1/36114 , A61N1/36117 , A61N1/36121 , A61N7/00 , A61N7/02 , A61N2007/0021 , A61N2007/003 , A61N2007/025
摘要: Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
-
公开(公告)号:US09950161B2
公开(公告)日:2018-04-24
申请号:US15189940
申请日:2016-06-22
发明人: Denise Zarins
IPC分类号: A61N1/05 , A61N1/36 , A61N1/20 , A61B18/14 , A61B18/12 , A61F7/10 , A61F7/12 , A61N1/32 , A61B18/00
CPC分类号: A61N1/36007 , A61B18/1206 , A61B18/1492 , A61B2018/0022 , A61B2018/00267 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00613 , A61F7/10 , A61F2007/126 , A61N1/05 , A61N1/0507 , A61N1/0551 , A61N1/0558 , A61N1/205 , A61N1/323 , A61N1/326 , A61N1/327 , A61N1/3605 , A61N1/36114 , A61N1/36117
摘要: Methods and apparatus are provided for multi-vessel neuromodulation, e.g., via a pulsed electric field. Such multi-vessel neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, the multi-vessel neuromodulation is applied to neural fibers that contribute to renal function. Such multi-vessel neuromodulation optionally may be performed bilaterally.
-
公开(公告)号:US20170361100A1
公开(公告)日:2017-12-21
申请号:US15636381
申请日:2017-06-28
发明人: Mark Deem , Denise Zarins , Douglas Sutton , Hanson Gifford, III , Howard R. Levin , Mark Gelfand , Benjamin J. Clark
CPC分类号: A61N1/36117 , A61B18/1492 , A61B2018/00267 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00613 , A61B2018/00702 , A61B2018/00779 , A61B2018/00791 , A61B2018/00875 , A61B2018/00982 , A61B2018/1435 , A61N1/0551 , A61N1/32 , A61N1/327 , A61N1/36007 , A61N1/36017 , A61N1/36128 , A61N5/00
摘要: Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.
-
公开(公告)号:US20170348050A1
公开(公告)日:2017-12-07
申请号:US15623428
申请日:2017-06-15
发明人: Denise Zarins , Hanson Gifford, III , Mark Deem , Howard R. Levin , Mark Gelfand , Nicolas Zadno
CPC分类号: A61B18/1492 , A61B18/12 , A61B18/1206 , A61B18/1482 , A61B18/16 , A61B2017/00154 , A61B2018/00059 , A61B2018/00214 , A61B2018/0022 , A61B2018/00261 , A61B2018/00267 , A61B2018/00279 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00613 , A61B2018/00642 , A61B2018/00648 , A61B2018/00791 , A61B2018/00875 , A61B2018/124 , A61B2018/1253 , A61B2018/1435 , A61B2018/1467 , A61B2018/1472 , A61N1/05 , A61N1/0551 , A61N1/327 , A61N1/36017 , A61N1/36117 , A61N1/36139
摘要: Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.
-
8.
公开(公告)号:US20170319271A1
公开(公告)日:2017-11-09
申请号:US15654018
申请日:2017-07-19
发明人: Andrew Wu , Benjamin J. Clark , Denise Zarins , Erik Thai
IPC分类号: A61B18/14 , A61B18/12 , A61M25/01 , A61B18/00 , A61B90/00 , A61B17/00 , A61B18/24 , A61B18/18 , A61B18/02 , A61N7/00
CPC分类号: A61B18/1492 , A61B18/02 , A61B18/1206 , A61B18/18 , A61B18/24 , A61B90/39 , A61B2017/003 , A61B2018/00172 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00648 , A61B2018/00791 , A61B2018/00875 , A61M25/0141 , A61N2007/003
摘要: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
-
公开(公告)号:US09757193B2
公开(公告)日:2017-09-12
申请号:US15141527
申请日:2016-04-28
发明人: Denise Zarins , Hanson Gifford, III , Mark Deem , Nicolas Zadno , Benjamin J. Clark , Andrew Wu , Kenneth J. Michlitsch
CPC分类号: A61B18/1492 , A61B18/1206 , A61B18/18 , A61B2018/00023 , A61B2018/00077 , A61B2018/0016 , A61B2018/0022 , A61B2018/00267 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00648 , A61B2018/00791 , A61B2018/00875 , A61B2018/124 , A61B2018/1435 , A61B2018/1465 , A61N1/0551 , A61N1/32 , A61N1/327 , A61N1/36007 , A61N7/022
摘要: Methods and apparatus are provided for non-continuous circumferential treatment of a body lumen. Apparatus may be positioned within a body lumen of a patient and may deliver energy at a first lengthwise and angular position to create a less-than-full circumferential treatment zone at the first position. The apparatus also may deliver energy at one or more additional lengthwise and angular positions within the body lumen to create less-than-full circumferential treatment zone(s) at the one or more additional positions that are offset lengthwise and angularly from the first treatment zone. Superimposition of the first treatment zone and the one or more additional treatment zones defines a non-continuous circumferential treatment zone without formation of a continuous circumferential lesion. Various embodiments of methods and apparatus for achieving such non-continuous circumferential treatment are provided.
-
公开(公告)号:US20170245926A1
公开(公告)日:2017-08-31
申请号:US15466594
申请日:2017-03-22
发明人: Denise Zarins , Hanson Gifford, III , Mark Deem , Douglas Sutton , Howard R. Levin , Mark Gelfand
CPC分类号: A61B18/1492 , A61B2018/0022 , A61B2018/00267 , A61B2018/00351 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00613 , A61F7/12 , A61F2007/126 , A61M5/14276 , A61M2210/1082 , A61M2210/12 , A61N1/05 , A61N1/327 , A61N1/36017 , A61N1/36114 , A61N1/36117 , A61N1/36121 , A61N7/00 , A61N7/02 , A61N2007/0021 , A61N2007/003 , A61N2007/025
摘要: Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
-
-
-
-
-
-
-
-
-